News

Launching the power of LitiGate across our network

We have officially launched LitiGate's AI-driven litigation platform across our network of contentious teams.

The firm has moved from a test phase of the tool on a select number of cases, to a rollout across the wider community of contentious practices involving its application to many of the most significant pieces of litigation or arbitration.

We chose LitiGate as our go-to litigation lifecycle platform to support clients with contentious matters, following our work with the platform's developers during the testing phase.

Catalent Supports Belgium-Based Cell and Gene Therapy Accelerator

Brussels South Charleroi BioPark (BSCB) recently announced it has launched a Cell and Gene Therapy Accelerator program to de-risk early stage research and create the advanced therapy companies of the future. Open to academic, industry or independent researchers across Europe, the program consists of an intensive bootcamp, workshops and coaching, plus access to Université libre de Bruxelles (ULB) Open BioLab and state-of-the-art technology platforms.

July 2021 eNews

Click here to view the July 2021 edition of eNews

June 2021 Dates for Your Diary

Click here to view the June edition of Dates for Your Diary

One Nucleus and BiotechBikers Announce Collaboration

Cambridge, UK: 30 June 2021

One Nucleus, the non-for-profit Life Science membership group headquartered in Cambridge exists to support growing Life Science businesses on their journey, including facilitating their business networking. BiotechBikers is a fast growing, informal global networking group in the Life Sciences space bringing together those with a social interest in cycling and biotech.

Using Lentivectors to Label Organoids

AMSBIO have supplied custom lentivectors to Francesco Pampaloni and his team at the Buchmann Institute for Molecular Life Sciences (BMLS) in Frankfurt, Germany allowing them to visualize cell nuclei and F-actin cytoskeleton in their organoids.

PharmaVentures acts as independent commercial expert with respect to Spectral MD’s IPO listing this month on London’s AIM

Oxford, UK, 29 June 2021: PharmaVentures is pleased to announce that it acted as an independent technical and commercial expert with respect to Spectral MD’s listing on London’s AIM on June 22nd.

Catalent Receives RoSPA Gold Award for Health and Safety Practices

SOMERSET, N.J., June 28, 2021 – Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it has been recognized by the Royal Society for the Prevention of Accidents (RoSPA) for demonstrating high health and safety standards.

Five Arrows invests in Sygnature Discovery

NOTTINGHAM, UK – 29 June, 2021 – Life Science Newswire – Sygnature Discovery, the leading provider of integrated drug discovery services, has received a significant investment from Five Arrows Principal Investments, the European corporate private equity arm of Rothschild & Co. Financial details have not been disclosed.

IONTAS collaboration with F-star enters oncology Phase 1 clinical trial

Cambridge, UK,– 29 June 2021: IONTAS Limited (IONTAS), a leader in the discovery and optimization of fully human antibodies, today announces that F-star Therapeutics, Inc. (NASDAQ: FSTX), has dosed the first patients in a Phase 1 clinical trial, with FS222, a CD137/PD-L1 bispecific antibody.

IONTAS applied its proprietary technology to generate a component utilized within FS222, which was subsequently licenced to F-star. The initiation of this trial adds to the growing portfolio of antibodies generated by IONTAS that are entering clinical trials.

My Account